ReN001

Type: Product
Name: ReN001
First reported Jun 18 2014 - Updated Jun 18 2014 - 3 reports

RENEURON : Confident For Future Despite Loss As It Advances Therapies

LONDON ( Alliance News ) - ReNeuron Group PLC Wednesday expressed confidence in its future as it continued to develop its stem-cell therapies towards commercialisation, and it posted a widened loss in the year to end-March.The company posted a pretax ... [Published 4 Traders - Jun 18 2014]
First reported Jun 18 2014 - Updated Jun 18 2014 - 1 reports

UK WINNERS & LOSERS: Iraq Crisis Lifts Oil Prices, Oil Companies

LONDON ( Alliance News ) - The following stocks are the leading risers and fallers within the main London indices midday Wednesday.-------FTSE 100 - WINNERS-------Royal Dutch Shell , up 1.9%. The oil major and state-owned China National Offshore Oil Corporation ... [Published HispanicBusiness.com - Jun 18 2014]
First reported May 16 2014 - Updated May 16 2014 - 1 reports

This week: Shoe Zone sizing up IPO, Flowtech powering towards AIM, Conroy Gold reaffirming strong portfolio

BLUR trading update,CGNR wide mineralised zones,Flowtech Fluidpower intention to float on AIM,Marimedia intention to float on AIM,PEG AGM Statement,RENE new data,RXB first day of dealings on AIM,Shoe Zone intention to float on AIM,XLM preliminary results,C21 ... [Published Proactiveinvestors United Kingdom RSS feed - May 16 2014]
First reported Mar 27 2014 - Updated Mar 28 2014 - 1 reports

Proactive news summary: Leni Gas & Oil, Mediterranean Oil & Gas, ReNeuron, San Leon Energy, Baobab Resources

Long-suffering shareholders in Mediterranean Oil & Gas ( LON:MOG ) were finally put out of their misery as the High Court ruled in its favour, leaving Leni Gas & Oil ( LON:LGO ) investors with a sour taste. LGO took MOG to court after selling it ... [Published Proactiveinvestors United Kingdom RSS feed - Mar 27 2014]
First reported Mar 27 2014 - Updated Mar 28 2014 - 2 reports

UK Clinical Trial Approvals

27 March 2014AIM: RENEReNeuron receives UK regulatory approvals for Phase II clinical trial in stroke and Phase I clinical trial in critical limb ischaemiaGuildford, UK, 27 March 2014:   ReNeuron Group  plc (the "Company") (AIM: RENE.L), a leading UK-based ... [Published TrustNet - Mar 27 2014]
First reported Mar 27 2014 - Updated Mar 27 2014 - 1 reports

Market movers: Power companies, Randgold Resources, Reneuron, Baobab, Sunrise

Miners and power companies were weighing heavy on Footsie in the first hour’s trading.  The blue chip index was trading 19 points lower at 6,585, while the flagship Aim index dipped 18 to 1,800. Power companies were making the headlines again as Britain's ... [Published Proactiveinvestors United Kingdom RSS feed - Mar 27 2014]
First reported Mar 14 2014 - Updated Mar 14 2014 - 1 reports

Support for Early Access to Medicines Scheme

14 March 2014 AIM: RENEReNeuron welcomes launch of UK Government Early Access to Medicines SchemeGuildford, UK, 14 March 2014:   ReNeuron Group   plc (the "Company") (AIM: RENE.L), a leading UK-based stem cell therapy company, welcomes today's announcement ... [Published TrustNet - Mar 14 2014]

Quotes

...6% in the 15 weeks to June 14 , boosted by growth at its Simply Be and Jacamo brands, with like-for-like growth up 2.5%. However, "numerically, it would perhaps be easy to see disappointment in the 2.5% first quarter like-for-likes" said Joe Spooner , an analyst at Jefferies. Bloomberg's survey of 12 analysts put the median expectation at 5.4%, with a range of 2% to 6...
...conducted with the Company's ReN009 candidate for critical limb ischaemia were published in the prestigious American Heart Association's Journal, "Arteriosclerosis, Thrombosis and Vascular"
"In both cases, and earlier-than-planned, we have gained regulatory approval to use a second-generation cryopreserved variant of our lead CTX stem cell line, providing the potential for significant commercial and competitive advantages for our business."
...Rex Bionics " marketed products: REX Rehab and REX Personal, can be used by people with complete spinal cord injury, but also by a much broader potential customer base, including people with multiple sclerosis and muscular dystrophy. "

More Content

All (12) | News (12) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
UK WINNERS & LOSERS: Iraq Crisis Lifts Oil Pric... [Published HispanicBusiness.com - Jun 18 2014]
RENEURON : Confident For Future Despite Loss As... [Published 4 Traders - Jun 18 2014]
ReNeuron Group plc : Preliminary Results [Published Investegate - Jun 18 2014]
ReNeuron upbeat after "transformational" year [Published Proactiveinvestors United Kingdom RSS feed - Jun 18 2014]
This week: Shoe Zone sizing up IPO, Flowtech po... [Published Proactiveinvestors United Kingdom RSS feed - May 16 2014]
Proactive news summary: Leni Gas & Oil, Mediter... [Published Proactiveinvestors United Kingdom RSS feed - Mar 27 2014]
Market movers: Power companies, Randgold Resour... [Published Proactiveinvestors United Kingdom RSS feed - Mar 27 2014]
UK Clinical Trial Approvals [Published TrustNet - Mar 27 2014]
Pace of progress quickens at ReNeuron as it get... [Published Proactiveinvestors United Kingdom RSS feed - Mar 27 2014]
Support for Early Access to Medicines Scheme [Published TrustNet - Mar 14 2014]
Interim Results [Published TrustNet - Dec 02 2013]
Notification of Interim Results [Published TrustNet - Nov 19 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.